- Home
- LSBPW vs PEBO Comparison
LSBPW vs PEBO Comparison
Compare LSBPW & PEBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSBPW
- PEBO
- Stock Information
- Founded
- LSBPW N/A
- PEBO 1902
- Country
- LSBPW China
- PEBO United States
- Employees
- LSBPW 758
- PEBO N/A
- Industry
- LSBPW Biotechnology: Pharmaceutical Preparations
- PEBO Major Banks
- Sector
- LSBPW Health Care
- PEBO Finance
- Exchange
- LSBPW Nasdaq
- PEBO Nasdaq
- Market Cap
- LSBPW N/A
- PEBO N/A
- IPO Year
- LSBPW N/A
- PEBO N/A
- Fundamental
- Price
- LSBPW $0.04
- PEBO $35.83
- Analyst Decision
- LSBPW
- PEBO Hold
- Analyst Count
- LSBPW 0
- PEBO 3
- Target Price
- LSBPW N/A
- PEBO $34.33
- AVG Volume (30 Days)
- LSBPW N/A
- PEBO 152.8K
- Earning Date
- LSBPW N/A
- PEBO 10-22-2024
- Dividend Yield
- LSBPW N/A
- PEBO 4.47%
- EPS Growth
- LSBPW N/A
- PEBO 3.01
- EPS
- LSBPW N/A
- PEBO 3.51
- Revenue
- LSBPW N/A
- PEBO $428,740,000.00
- Revenue This Year
- LSBPW N/A
- PEBO N/A
- Revenue Next Year
- LSBPW N/A
- PEBO $1.10
- P/E Ratio
- LSBPW N/A
- PEBO $10.21
- Revenue Growth
- LSBPW N/A
- PEBO 10.64
- 52 Week Low
- LSBPW N/A
- PEBO $26.74
- 52 Week High
- LSBPW N/A
- PEBO $36.19
- Technical
- Relative Strength Index (RSI)
- LSBPW N/A
- PEBO 66.37
- Support Level
- LSBPW N/A
- PEBO $34.24
- Resistance Level
- LSBPW N/A
- PEBO $35.81
- Average True Range (ATR)
- LSBPW 0.00
- PEBO 0.97
- MACD
- LSBPW 0.00
- PEBO 0.06
- Stochastic Oscillator
- LSBPW 0.00
- PEBO 93.90
About LSBPW LakeShore Biopharma Co. Ltd
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.